Literature DB >> 22071460

Levetiracetam-induced interstitial nephritis in a patient with glioma.

Ali Mahta1, Ryan Y Kim, Santosh Kesari.   

Abstract

A 45-year-old man with a new diagnosis of low grade glioma was started on an escalating dose of levetiracetam (Lev) for seizure management. He gradually developed intractable nausea/vomiting and a high creatinine concentration due to acute renal failure which was attributed to Lev-induced interstitial nephritis. The medication was changed and his renal function rapidly improved to his baseline.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22071460     DOI： 10.1016/j.jocn.2011.08.007

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN： 0967-5868            Impact factor:   1.961


  3 in total

1.  Population-Based Study of Risk of AKI with Levetiracetam.

Authors:  Kevin Yau; Jorge G Burneo; Racquel Jandoc; Eric McArthur; Flory Tsobo Muanda; Chirag R Parikh; Ron Wald; Matthew A Weir; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2018-12-11       Impact factor: 8.237

2.  Creatine phosphokinase elevation exacerbated by levetiracetam therapy.

Authors:  Julia E Isaacson; Dongwhoon J Choe; Michael J Doherty
Journal:  Epilepsy Behav Case Rep       Date:  2014-10-22

Review 3.  Cocaine-Induced Acute Interstitial Nephritis: A Comparative Review of 7 Cases.

Authors:  Faisal Inayat; Syed Rizwan A Bokhari; Lisa Roberts; Raquel M Rosen
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.